Skip to main content
Clinical Trials/IRCT201411037984N22
IRCT201411037984N22CompletedPhase 2

Comparison of the pain in transforaminal epidural steroid injections and pulsed radiofrequency in patients with low back pain

Vice chancellor for research, Tehran University of Medical Sciences and Health Services0 sites42 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
42

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Main inclusion criteria:
  • Persistent low back pain with or without pain radiating to the upper leg; Age > 18 years old; ASA Class I- II; Lasek test =>50 degrees; Confirming the involvement of nerve roots , vertebral disc protrusion is based on clinical examination and CT scan and MRI findings; Symptoms of chronic low back pain for more than six months; Absence of neurological defects; Absence of epidural injection; Absence of radicular syndrome; No respond to traditional treatments; Positive diagnostic block; Hyperextension pain; No history of lumbar surgery; Contraindication of lumbar surgery; Signing consent to participate in the study.
  • Main exclusion criteria:
  • Patients previously treated with radiofrequency; Coagulation disorders; Contrast sensitivity radio- opaque or local anesthetic solution; Malignancy; Psychiatric problems and poor patient cooperation; Speech problems; Pregnancy; Surgery indication; Local skin infection at the operative site; Spinal deformities; Spinal stenosis; Discogenic axial pain; Degenerative disc herniation; Epidural injection of steroids in the past six months; History of opioid abuse; Use of long -acting opioids recent Radicular pain over a year ago; Patients with a history of sensitivity to corticosteroids or contrast material; Inflammatory spondylopathy; Vertebral fracture , tumor , or infection of the spine; No signing consent to participate in the study.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Tehran University of Medical Sciences and Health Services

Similar Trials